होमAthleticsRuti Aga Handed Six-Year Ban: Fake Prescription Written by a Family Member Ends Marathon Runner's Career
Athletics

Ruti Aga Handed Six-Year Ban: Fake Prescription Written by a Family Member Ends Marathon Runner's Career

रूति आगा, इथियोपिया की मैराथन धाविका, को एथलेटिक्स इंटीग्रिटी यूनिट ने छह साल के लिए प्रतिबंधित किया है। मार्च में चीन की एक आधी मैराथन जीतने के बाद उनके नमूने में मिथाइलप्रेडनिसोलोन मिला, जो वाडा सूची की एस9 श्रेणी का ग्लूकोकॉर्टिकॉइड है और केवल प्रतियोगिता के दौरान प्रतिबंधित है, एनाबॉलिक स्टेरॉयड नहीं। सजा दो हिस्सों में है: पदार्थ की मौजूदगी पर दो साल और फर्जी प्रिस्क्रिप्शन पेश करके छेड़छाड़ करने पर चार साल। वह प्रिस्क्रिप्शन परिवार के एक ऐसे सदस्य ने लिखा था जिसके पास चिकित्सकीय पंजीकरण नहीं था और जिस क्लिनिक का नाम पर्ची पर था वह अस्तित्व में ही नहीं था। प्रतिबंध 10 सितंबर से लागू है, जो उनके अनंतिम निलंबन की तारीख है, और 32 वर्षीय धाविका के लिए यह 2028 ओलंपिक चक्र तथा व्यवहार में पूरा करियर समाप्त कर देता है। उनका 2019 टोक्यो मैराथन खिताब और तीन मेजर उपविजेता स्थान स्वत: रद्द नहीं होते, लेकिन मार्च की उस दौड़ का नतीजा और पुरस्कार राशि रद्द होने की संभावना बहुत अधिक है।

Ethiopian marathon runner Ruti Aga has been banned for six years by the Athletics Integrity Unit (AIU), a sanction announced in a statement issued on Thursday. The case is notable less for the substance involved than for the document the athlete submitted to defend herself, which investigators found to be entirely fabricated. According to the AIU, Aga tested positive for methylprednisolone after winning a half marathon in China in March. No mark, split or field quality was disclosed for that race, but the existence of an AIU test implies it was a World Athletics Label road race with an elite women's field and in-competition testing. A technical correction is essential here. Methylprednisolone was widely described as a prohibited anabolic steroid; it is not. It is a glucocorticoid, listed under class S9 of the WADA Prohibited List. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only when administered by injection, orally or rectally. A therapeutic knee injection given out of competition is entirely legal and becomes a violation only if residues are present in-competition. The in-competition testing window for a road race opens at 23:59 the day before the race, which is why timing and route of administration, not steroid use, are the decisive legal facts. Aga's defence was that she had been treated for a knee injury. The prescription she produced failed verification on three independent counts. The clinic named on it did not exist. The person who wrote it, described as a doctor, was a family member with no medical registration. And when questioned, that person claimed to have used an old prescription pad from a former workplace, a claim the clinic explicitly disowned. The AIU charged two separate violations: presence of a prohibited substance, carrying two years, and tampering, carrying four years for providing misleading information and a fabricated document. Six years in total. The arithmetic is revealing. Two years is consistent with a specified-substance finding without proven intent. The separate four-year sanction shows the panel rejected any mitigation on the presence charge and treated the tampering as fully culpable. The forged document became the heaviest evidence against her. The ban runs from 10 September, the date her provisional suspension began. Backdating is a procedural mechanism, not a reduction: the months already served are simply counted. In practical terms, the sanction removes her from the entire 2028 Olympic cycle. Aga is 32. She will be around 38 when the ban expires. Given the depth of Ethiopian women's marathoning, a 38-year-old returning athlete with a doping record is effectively unselectable. On paper the ban is six years; for elite purposes it is a career ending. That is a harsh outcome for an athlete who was genuinely elite. She won the 2026 Tokyo Marathon, a World Marathon Major, and has three second-place finishes at Majors to her name. Her personal best is in the 2:18 range, set in Berlin in 2026, with a 2:20-winning run in Tokyo in 2026. Those figures come from external records and should be treated as pending verification, but a 2:18 to 2:20 marathoner is a serious national-team contender in any country. On the scope of disqualification, the violation is anchored to the March race. Absent a finding of earlier use, results before that date, including the 2026 Tokyo title, are not automatically annulled. The March race result and its prize money, however, are very likely voided under standard AIU practice, even though the statement does not say so explicitly. The knee injury explanation is mechanistically plausible. Intra-articular or peri-articular glucocorticoid injection for knee synovitis is routine sports medicine in distance runners. That plausibility is precisely why the forgery is decisive: a genuinely documented treatment would have been defended with real records. A properly managed athlete would either have held or applied for a Therapeutic Use Exemption or observed the route-specific washout period. Neither appears to have happened. The doctor was a relative, the clinic did not exist. This is not a filing error; it is the signature of an athlete operating without a credentialed team physician, a governance failure familiar across East African road-running entourages. The four-year tampering sanction arises from an interview, meaning statements made under questioning, not from a document alone. Language and translation conditions in AIU interviews with Ethiopian athletes are a recurring point of contention, though a documentary forgery finding is hard to overturn on that basis alone. Structurally, the sanction is standard, not exceptional. What is exceptional is the proportionality optics: a six-year ban for a glucocorticoid with no proven endurance benefit will be cited both as evidence of AIU rigour and as evidence of aggressive enforcement against African road runners. There is also a market dimension. Chinese half marathons and marathons function as a lucrative, low-risk income tier for East African marathoners between Majors. That same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races. The competitive landscape is unaffected. Ethiopia's women's marathon depth is such that removing one 32-year-old with no global championship medals changes nothing in selection calculus. Kenya's strength lies in converting championship races; Ethiopia's in top-end depth. Both systems are structurally deep and structurally exposed to entourage-level governance failure. A broader pattern is visible: AIU road-running cases from the region increasingly follow a sequence in which a substance violation is compounded by a fabricated explanation, and the sanction ends up heavier because of the cover-up than the substance. The enforcement frontier has shifted from detection to document verification. Because the same informal medical networks serve many athletes in the same training clusters, more such cases are likely in the pipeline. An appeal to the Court of Arbitration for Sport remains possible, typically within about 21 days of the reasoned decision, but success is unlikely given the documentary basis of the forgery finding. A further, unaddressed exposure exists: document forgery may be a criminal matter in some jurisdictions, outside the AIU's remit but open to national referral. The essential lesson is that this is a document case, not a drug case. The injection was legal out of competition; correct timing and route might have produced no case at all; genuine medical records with a clear explanation could have supported mitigation on the presence charge and no tampering charge whatsoever. The moment a family member wrote a prescription on behalf of a clinic that did not exist, a likely two-year absence became a six-year career death. For athletes, the takeaway is direct: knowing which WADA class a medication falls into matters as much as race preparation. Glucocorticoids are prohibited in-competition, not out. Timing, route and documentation together form the defence. And honesty in a crisis is cheaper than any fabrication. What Aga lost is not only six years; she turned a fight she might have won into one she lost herself.

Ruti Aga Handed Six-Year Ban: Fake Prescription Written by a Family Member Ends Marathon Runner's Career

Ruti Aga Handed Six-Year Ban: Fake Prescription Written by a Family Member Ends Marathon Runner's Career

संबंधित खिलाड़ी